Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
Medicinal chemists paly a crucial role in the drug discovery process through the selection and synthesis of compounds that establish structure–activity relationships and achieve efficacy and safety in ...
Hellgren et al. develop AEGIS, a transcriptomics-based tool that quantifies apoptosis-linked gene signatures to assess drug-induced liver injury risk across doses, in vitro models, species, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback